Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05779930
Title Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nationwide Children's Hospital
Indications
Therapies
Age Groups: child | adult
Covered Countries USA


No variant requirements are available.